Penka Kovacheva of Cornerstone Research discussed the impact of M&A on innovation in the pharmaceutical industry during a podcast hosted by the American Bar Association (ABA).
Dr. Kovacheva spoke with the hosts of the ABA Antitrust Law Section podcast, Our Curious Amalgam, about her recent coauthored article published in Concurrences Competition Law Review, “The impact of pharmaceutical M&A on innovation: Insights from the literature and gaps remaining.”
Dr. Kovacheva, who coheads Cornerstone Research’s life sciences practice, discussed how economists are attempting to measure the impact of M&A on innovation, as regulators are signaling increased scrutiny of pharmaceutical mergers.
Episode details are available at the ABA website.
The views expressed herein do not necessarily represent the views of Cornerstone Research.
Los Angeles
